The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

The lawsuit aims to seek damages for the investors who felt the company was not being honest about the drug’s potential ...

(Bloomberg) -- GSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac ...

A separate $70 million settlement has been agreed to settle a whistleblower complaint brought by Valisure, an independent Connecticut laboratory that alleged that GSK violated the federal False ...

GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract infections (uUTIs) in female adults and adolescents. A commercial launch ...

working his way up from a lab role and holding a series of senior positions at the company, most recently as head of investor relations. He was due to start at GSK this morning to lead the ...